Literature DB >> 18049091

Added value of PET and PET-CT in oesophageal cancer: a review of current practice.

Sobhan Vinjamuri1, Soumendranath Ray.   

Abstract

Oesophageal carcinoma is a relatively rare form of cancer. However, it is also one of the most deadly forms of cancer, with a 5-year survival rate of only 3% for patients with nodal disease, and 42% for those without nodal disease. It is therefore very important to accurately stage the disease at diagnosis and before therapy. In this article, we review the role of commonly used investigative techniques in the diagnosis and staging of oesophageal carcinoma, with special emphasis on PET and PET-CT scanning. The literature is reviewed in the context of our recent experience. A retrospective review of 129 patients with oesophageal carcinoma, who underwent PET or PET-CT scanning over a 24-month period confirmed the incremental value of PET and PET-CT scanning in the staging of oesophageal carcinoma.

Entities:  

Mesh:

Year:  2008        PMID: 18049091     DOI: 10.1097/MNM.0b013e3282f1b9c7

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  3 in total

1.  Oesophageal cancer: can imaging improve its assessment?

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10       Impact factor: 9.236

2.  Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning.

Authors:  Karim Sillah; Luke R Williams; Hans-Ulrich Laasch; Azeem Saleem; Gillian Watkins; Susan A Pritchard; Patricia M Price; Catharine M West; Ian M Welch
Journal:  World J Gastrointest Oncol       Date:  2010-04-15

3.  Investigation of dose minimisation protocol for 18F-FDG PET-CT in the management of lymphoma postchemotherapy followup.

Authors:  L I Sonoda; B Sanghera; W L Wong
Journal:  ScientificWorldJournal       Date:  2012-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.